Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES (GILD)
Add to my list  
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/14/2017 11/15/2017 11/16/2017 11/17/2017 11/20/2017 Date
71.15(c) 71.81(c) 72.41(c) 72.44(c) 71.8213 Last
10 925 635 8 539 315 7 535 925 5 719 061 815 622 Volume
-2.33% +0.93% +0.84% +0.04% -0.85% Change
More quotes
Financials ($)
Sales 2017 25 806 M
EBIT 2017 15 765 M
Net income 2017 10 588 M
Debt 2017 12 742 M
Yield 2017 2,92%
Sales 2018 22 267 M
EBIT 2018 12 632 M
Net income 2018 8 015 M
Debt 2018 10 185 M
Yield 2018 3,13%
P/E ratio 2017 9,25
P/E ratio 2018 11,75
EV / Sales2017 4,16x
EV / Sales2018 4,71x
Capitalization 94 601 M
More Financials
Company
Gilead Sciences, Inc. is a biopharmaceutical company, which discovers, develops and commercializes therapeutics for unmet medical need.It focuses on human immunodeficiency virus and liver diseases, such as chronic hepatitis C virus infection & chronic hepatitis B virus infection, hematology &... 
More about the company
Surperformance© ratings of Gilead Sciences
Trading Rating : Investor Rating :
More Ratings
Latest news on GILEAD SCIENCES
02:18p SPRING BANK PHARMACEUTICALS : Announces Positive Top-Line Results from the Secon..
11/15 GILEAD SCIENCES : Today’s Research Reports on Trending Tickers: Gilead Sciences ..
11/09 GILEAD SCIENCES : Columnist Shreds Gilead's Lame Excuses for Sky-High Drug Price..
11/09 GILEAD SCIENCES : New Findings in DNA Research Described from Gilead Sciences (D..
11/07 GILEAD SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
11/04 GILEAD SCIENCES : Abraham Brass Receives Grant From Gilead for HIV Research
11/04 GILEAD SCIENCES : Analysts See $2.07 EPS for Gilead Sciences, Inc. (GILD)
11/02 GILEAD SCIENCES : to Present at the Credit Suisse 26th Annual Healthcare Confere..
11/02 GILEAD SCIENCES : New Findings from Gilead Sciences Describe Advances in Antibio..
10/31 Pfizer expects broad interest for consumer health business
More news
Sector news : Bio Therapeutic Drugs
11/16 Recovery rally for European stocks leaves oil sector behind
11/13 Poor earnings updates keep European shares at seven-week low
11/13DJNOVARTIS : Vision Drug Shows Positive Results in Phase 3 Trials
11/03 Prosecutors search Metro offices in insider trading probe
11/01DJAs Experimental Treatments Grow, Families Face Tough Choices
More sector news : Bio Therapeutic Drugs
4-Traders Strategies on GILEAD SCIENCES 
GILEAD SCIENCES - 2014
A valuable trading opportunity
BUY
GILEAD SCIENCES - 2014
Continuation of the bullish trend
BUY
More Strategies
News from SeekingAlpha
11/19 Victory Formation Long/Short Portfolio Update - November 2017
11/19 GILEAD SCIENCES : Tapping Into The Vast China Market For Growth
11/18 Stocks to watch next week
11/17 YOUR DAILY PHARMA SCOOP : Gilead CAR-T Potential, Egalet Surges, Aerie Launches ..
11/16 2017 Cigar Butts More Soggy Than Smoke - Low EV/EBIT Large And Midcap YTD Upd..
Chart GILEAD SCIENCES
Duration : Period :
Gilead Sciences Technical Analysis Chart | GILD | US3755581036 | 4-Traders
Technical analysis trends GILEAD SCIENCES
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 84,9 $
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
John F. Milligan President, Chief Executive Officer & Director
John C. Martin Executive Chairman
Kevin B. Young Chief Operating Officer
Robin L. Washington Chief Financial Officer & Executive Vice President
Norbert W. Bischofberger Chief Scientific Officer & Executive VP-Research
Sector and Competitors
1st jan.Capitalization (M$)
GILEAD SCIENCES1.16%94 601
REGENERON PHARMACEUTICALS6.67%42 072
VERTEX PHARMACEUTICALS100.10%37 280
GENMAB4.43%11 878
EXELIXIS, INC.76.93%7 805
BLUEBIRD BIO INC164.51%7 480